7th Annual Ion Channel Retreat
Vancouver BC, Canada • June 29 – July 1, 2009
Marriott Vancouver Pinnacle Downtown
write us at retreat@aurorabiomed.com
For 2008 Ion Channel Retreat Review, please click here
Aurora Biomed invites you to attend the 7th Annual Ion Channel Retreat. Our goal is to create a forum for scientific discourse spanning the spectrum of ion channel disciplines. Researchers from both academia and industry are invited to share knowledge for the advancement of ion channel research, ion channel technology, drug discovery and safety pharmacology.
Meeting Format: The Ion Channel Retreat is a 3-day meeting encompassing several diverse areas of ion channel research. The sessions begin on Monday June 29th and end mid-afternoon on Wednesday, July 1st. Poster presentations will be available for viewing during all session breaks.
Program Sessions: Ion Channel Retreat Sessions will include, but are not limited to:
- Ion Channel Screening Technologies
- Ion Channels in Safety Pharmacology
- Ion Channel Structure & Function
- Ion Channels in Disease Pathology
- New Horizons in Ion Channel Research
2009 Scientific Advisory Board
Bernard Fermini
Associate Director, Global Safety Pharmacology, DSRD
Pfizer Inc
Georg C. Terstappen
Chief Scientific Officer
Siena Biotech S.P.A.
Michael A. Dabrowski
Associate Principal Scientist, AstraZeneca CNS & Pain Local Discovery Södertälje
Astrazeneca
Shephali Trivedi
Associate Director, HTS Center and Global Support Department
AstraZeneca Pharmaceuticals LP
Tony Priestley
Director, Molecular Pharmacology, Neurobiology Department
Schering-Plough Research Institute
Wei Zheng
National Institutes of Health, National Human Genome Research Institute
NIH Chemical Genomics Center
New Horizons Scientific Advisory Board
Craig T. January
Professor, Division of Cardiovascular Medicine & Co-founder: Cellular Dynamics International
University of Wisconsin-Madison
Timothy J. Kamp
Professor of Medicine and Physiology & Co-director Stem Cell and Regenerative Medicine Center
University of Wisconsin-Madison
Umesh A. Patel
Director - Drug Discovery
Millipore BioScience Division
Preliminary Speakers
Damian Wheeler (Post-Doctoral Fellow)
Stanford University
Gerhard Meissner (Professor)
University of North Carolina, Chapel Hill
Merritt Maduke (Assistant Professor)
Stanford University School of Medicine
Raad Nashmi (Assistant Professor)
University Of Victoria
Gregory Kaczorowski (Adjunct Professor)
University of Medicine and Dentistry of New Jersey;
Robert Wood Johnson Medical School
Wei Zheng (Group leader)
NIH
Søren Friis (Investigator)
Sophion Bioscience
Craig T. January (Doctor of Medicine)
University of Wisconsin-Madison / Cellular Dynamics
Paul Li (Associate Professor)
Simon Fraser University
Bernard Fermini (Associate Director)
Global Safety Pharmacology, DSRD Pfizer
Jeff Clare (Director Of R&D, Ion Channel Group)
Millipore
Zhiyuan Li (Investigator)
Guangzhou Institute Of Biomedicine And Health
Christine Beeton (Assistant Professor)
Baylor College of Medicine (Houston, Texas)
Heike Wulff (Associate Professor)
University of California
Georg Terstappen ()
Siena Biotech
David Fedida (Professor; Associate Head; Associate Dean)
University of British Columbia, Faculty of Medicine
Jerrel Yakel (Senior Investigator)
NIH
Alan Wickenden (Research Fellow)
Johnson & Johnson
Andreas Jeromin (Manager)
Allen Institute For Brain Science
James Miller (Principal Scientist)
Principal Scientist, Elan Pharmaceuticals
Richard Mccombie (Professor)
CSHL
Steve Stice (Director)
ADS Rhodes Complex University of Georgia University of Georgia
Tim Kamp (Cofounder)
Cellular Dynamics International
Clive Glover (Product Manager)
Stemcell Technologies Inc.
Sharona E. Gordon (Associate Professor)
University of Washington
John "Jack" Stewart (Chief Scientific Officer)
BioProspecting NB Inc.
Michael Dabrowski (Associate Principal Scientist)
AstraZeneca CNS&Pain Local Discovery Södertälje |
|
Call for Papers
Aurora Biomed is currently finalizing the speaking program. Please contact us directly at retreat@aurorabiomed.com for further information regarding speaking opportunities. Upon submission, authors give Aurora Biomed the right to publish abstracts in any format before, during, and after the meeting.
Submission Information Deadline:
March 1, 2009 Oral / Poster Presentation Abstracts
Assay and Drug Development Technologies
This peer-reviewed Medline journal will publish a special issue including papers submitted from the 2009 Ion Channel Retreat, as well as the 2009 Retreat Review. The 2008 Meeting Review is published in the December 2008 (Volume 6, issue 6) issue of ADDT.
2009 Registration Information
Click here for Online Registration Form
PAYMENTS MUST BE RECEIVED FIFTEEN (15) DAYS PRIOR TO THE CONFERENCE
EARLY BIRD DEADLINE EXTENDED TO APRIL 15TH!
Register online and pay before March 31st to take advantage of early bird registration fees.
- Registrations received on or before March 31st 2009:
- Academic Registration Fee $ 349.00 (USD)
- Industry Registration Fee $ 699.00 (USD)
- Registrations Received after March 31st 2009:
- Academic Registration Fee $ 399.00 (USD)
- Industry Registration Fee $ 799.00 (USD)
Register by Phone:
To register by phone, or for additional information, please call Aurora Biomed at 604-215-8700.
Payments:
The registration fee for this Conference includes all breakfasts, lunches, refreshments and a banquet. Payment may be made by Visa or Mastercard.
Hotel:
Reserve a Room at Vancouver Marriott Pinnacle Downtown
Register BEFORE June 8th for Special Conference rate of only $199 / night
For other alternatives please contact Aurora at retreat@aurorabiomed.com
| Corporate Sponsors |
 |
 |
 |
 |
 |
 |
 |
| Media Sponsors |
 |
 |
 |
| Media Partners |
 |
 |
 |
 |
 |
|
